Oaktree Specialty Lending (OCSL) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
3 Mar, 2026Opening remarks and agenda
Meeting called to order and stockholders welcomed to the 2026 Annual Meeting of Stockholders.
Stockholders encouraged to submit questions via the virtual portal; management and auditors available for Q&A after adjournment.
Inspector of Election appointed and quorum confirmed for conducting business.
Agenda included election of two directors and ratification of the independent auditor.
Board and executive committee updates
Two directors, John B. Frank and Bruce Zimmerman, nominated for election to serve until the 2029 Annual Meeting.
Shareholder proposals
Proposals included election of directors and ratification of Ernst & Young LLP as independent auditor for fiscal year ending September 30, 2026.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Oaktree Specialty Lending
- $2.9B portfolio, 86% senior secured, strong liquidity, and stable income with robust new investments.OCSL
Investor presentation10 Mar 2026 - Net investment income covered the dividend as NAV fell and new investments remained strong.OCSL
Q1 20264 Feb 2026 - Shareholders to vote on authorizing stock issuance below NAV, up to 25% of shares.OCSL
Proxy Filing2 Feb 2026 - Adjusted NII per share $0.55, NAV $18.19, fee cut, and $0.55/share dividend declared.OCSL
Q3 20242 Feb 2026 - Election of two directors and auditor ratification are up for vote at the 2026 annual meeting.OCSL
Proxy Filing16 Jan 2026 - Shareholders will vote on director elections and auditor ratification, with strong governance oversight.OCSL
Proxy Filing16 Jan 2026 - Q4 NII steady at $0.55/share; NAV down to $18.09; strong liquidity; higher non-accruals.OCSL
Q4 202413 Jan 2026 - Oaktree's $100M equity at NAV boosts liquidity as income dips and new dividend policy starts.OCSL
Q1 20258 Jan 2026 - Stockholders are asked to approve potential issuance of shares below NAV, capped at 25%.OCSL
Proxy Filing8 Jan 2026